Literature DB >> 11157413

Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status.

M F Sowers1, J L Beebe, D McConnell, J Randolph, M Jannausch.   

Abstract

While there is substantial evidence of the importance of endogenous and exogenous estrogen in reproductive health and chronic disease, there is little consideration of androgens in women's health. In the Michigan Bone Health Study (1992-1995), the authors examined the correlates of testosterone concentrations in pre- and perimenopausal women (i.e., age, menopausal status, body composition, and lifestyle behaviors) in a population-based longitudinal study including three annual examinations among 611 women aged 25-50 years identified through a census in a midwestern community. Current smokers had the highest testosterone concentrations with decreasing values in former and nonsmokers (p = 0.0001). Body composition measures (body mass index, body fat (%), weight (kg), lean body mass (kg), and fat mass (kg)) were significantly and positively associated with total testosterone concentrations in a dose-response manner. Hysterectomy with oophorectomy was associated with significantly lower testosterone concentrations. Alcohol consumption, physical activity, and dietary macronutrient intake were not associated with testosterone concentrations. This is one of the first studies to examine correlates of serum testosterone concentrations in anticipation of the growing interest in the role of androgens in women's health. The greater circulating levels of testosterone in obese women and smokers suggest that testosterone concentrations should be considered in the natural history of disease conditions where obesity and smoking are risk factors, including cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157413     DOI: 10.1093/aje/153.3.256

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  44 in total

1.  Age at Onset of Metabolic Syndrome Among Women With and Without Polycystic Ovary Syndrome-Like Status.

Authors:  Qing Peng; Carrie A Karvonen-Gutierrez; John F Randolph; Bin Nan; Daniel McConnell; Siobán D Harlow
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation.

Authors:  Rachel P Wildman; Ping G Tepper; Sybil Crawford; Joel S Finkelstein; Kim Sutton-Tyrrell; Rebecca C Thurston; Nanette Santoro; Barbara Sternfeld; Gail A Greendale
Journal:  J Clin Endocrinol Metab       Date:  2012-06-21       Impact factor: 5.958

3.  Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women.

Authors:  Jonas Manjer; Robert Johansson; Per Lenner
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Smoking affects womens' sex hormone-regulated body form.

Authors:  Mari Pölkki; Markus J Rantala
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

5.  Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Cindy Ta Pau; Candace C Keefe; Corrine K Welt
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

6.  Relationship of androgens to body composition, energy and substrate metabolism and aerobic capacity in healthy, young women.

Authors:  Jennifer L Keller; Peter R Casson; Michael J Toth
Journal:  Steroids       Date:  2011-06-25       Impact factor: 2.668

7.  Smoking Across the Menopausal Transition in a 10-Year Longitudinal Sample: The Role of Sex Hormones and Depressive Symptoms.

Authors:  MacKenzie R Peltier; José M Flores; Philip H Smith; Walter Roberts; Terril L Verplaetse; Kelly E Moore; Robyn Hacker; Lindsay M Oberleitner; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2020-05-26       Impact factor: 4.244

8.  Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.

Authors:  H R Harris; L J Titus; D W Cramer; K L Terry
Journal:  Int J Cancer       Date:  2016-10-06       Impact factor: 7.396

9.  Racial differences in women who have a hysterectomy for benign conditions.

Authors:  Gerson Weiss; Dorette Noorhasan; Laura L Schott; Lynda Powell; John F Randolph; Janet M Johnston
Journal:  Womens Health Issues       Date:  2009 May-Jun

10.  Vascular endothelial growth factor and breast cancer risk.

Authors:  Katherine W Reeves; Roberta B Ness; Roslyn A Stone; Joel L Weissfeld; Victor G Vogel; Robert W Powers; Francesmary Modugno; Jane A Cauley
Journal:  Cancer Causes Control       Date:  2008-11-06       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.